In summary, we show that mTOR inhibition results in the feedback activation of translation programs in 4EBP1 lacking pancreatic cancer cells, and targeting translation downstream of mTOR may be a better therapeutic strategy in pancreatic cancer. The gene discussed is EIF4EBP1; the disease is pancreatic neoplasm.